GSK ends Ebola vaccine RnD; transfers license to US institute Medical Dialogues Bureau8 Aug 2019 9:30 AM ISTGSK had put its Ebola vaccine work on hold after it was unable to progress the product through the final stage, or Phase III, clinical trials toward...